Literature DB >> 23774214

14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.

Sangphil Oh1, Sook Shin, Stan A Lightfoot, Ralf Janknecht.   

Abstract

Overexpression of the ETS-related transcription factor ETV1 can initiate neoplastic transformation of the prostate. ETV1 activity is highly regulated by phosphorylation, but the underlying mechanisms are unknown. Here we report that all 14-3-3 proteins, with the exception of the tumor suppressor 14-3-3σ, can bind to ETV1 in a condition manner dictated by its prominent phosphorylation site S216. Non-σ 14-3-3 proteins synergized with ETV1 to activate transcription of its target genes MMP-1 and MMP-7, which regulate extracellular matrix in the prostate tumor microenvironment. S216 mutation or 14-3-3τ downregulation was sufficient to reduce ETV1 protein levels in prostate cancer cells, indicating that non-σ 14-3-3 proteins protect ETV1 from degradation. Notably, S216 mutation also decreased ETV1-dependent migration and invasion in benign prostate cells. Downregulation of 14-3-3τ reduced prostate cancer cell invasion and growth in the same manner as ETV1 attenuation. Finally, we showed that 14-3-3τ and 14-3-3ε were overexpressed in human prostate tumors. Taken together, our results showed that non-σ 14-3-3 proteins are important modulators of ETV1 function that promote prostate tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774214      PMCID: PMC3745528          DOI: 10.1158/0008-5472.CAN-13-0578

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14.

Authors:  Ana Soloaga; Stuart Thomson; Giselle R Wiggin; Navita Rampersaud; Mark H Dyson; Catherine A Hazzalin; Louis C Mahadevan; J Simon C Arthur
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

2.  High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma.

Authors:  Johanna Nikkola; Pia Vihinen; Tatyana Vlaykova; Marjo Hahka-Kemppinen; Veli-Matti Kähäri; Seppo Pyrhönen
Journal:  Int J Cancer       Date:  2002-02-01       Impact factor: 7.396

3.  HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1.

Authors:  D G Bosc; B S Goueli; R Janknecht
Journal:  Oncogene       Date:  2001-09-27       Impact factor: 9.867

4.  Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300.

Authors:  S Papoutsopoulou; R Janknecht
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

5.  Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

Authors:  J B Welsh; L M Sapinoso; A I Su; S G Kern; J Wang-Rodriguez; C A Moskaluk; H F Frierson; G M Hampton
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

6.  ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.

Authors:  Sook Shin; Sangphil Oh; Seayoon An; Ralf Janknecht
Journal:  Oncol Rep       Date:  2012-10-16       Impact factor: 3.906

7.  Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.

Authors:  Apollina Goel; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

8.  Gene expression correlates of clinical prostate cancer behavior.

Authors:  Dinesh Singh; Phillip G Febbo; Kenneth Ross; Donald G Jackson; Judith Manola; Christine Ladd; Pablo Tamayo; Andrew A Renshaw; Anthony V D'Amico; Jerome P Richie; Eric S Lander; Massimo Loda; Philip W Kantoff; Todd R Golub; William R Sellers
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

9.  Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1).

Authors:  Ralf Janknecht
Journal:  Oncogene       Date:  2003-02-06       Impact factor: 9.867

10.  Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A.

Authors:  Jianmin Wu; Ralf Janknecht
Journal:  J Biol Chem       Date:  2002-09-03       Impact factor: 5.157

View more
  21 in total

1.  WRINKLED1 as a novel 14-3-3 client: function of 14-3-3 proteins in plant lipid metabolism.

Authors:  Que Kong; Wei Ma
Journal:  Plant Signal Behav       Date:  2018-08-01

2.  Molecular Mechanism of β-Catenin Signaling Pathway Inactivation in ETV1-Positive Prostate Cancers.

Authors:  Sharif Morsalin; Chunshu Yang; Jinbo Fang; Sampreet Reddy; Shubhalaxmi Kayarthodi; Ed Childs; Roland Matthews; Veena N Rao; E Shyam P Reddy
Journal:  J Pharm Sci Pharmacol       Date:  2015-09

3.  Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions.

Authors:  Siaw Shi Boon; Vjekoslav Tomaić; Miranda Thomas; Sally Roberts; Lawrence Banks
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

4.  Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.

Authors:  Tae-Dong Kim; James R Fuchs; Eric Schwartz; Dalia Abdelhamid; Jonathan Etter; William L Berry; Chenglong Li; Michael A Ihnat; Pui-Kai Li; Ralf Janknecht
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

5.  Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.

Authors:  Tae-Dong Kim; Fang Jin; Sook Shin; Sangphil Oh; Stan A Lightfoot; Joseph P Grande; Aaron J Johnson; Jan M van Deursen; Jonathan D Wren; Ralf Janknecht
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

6.  Upregulation of PSMD10 caused by the JMJD2A histone demethylase.

Authors:  Tae-Dong Kim; Sangphil Oh; Stan A Lightfoot; Sook Shin; Jonathan D Wren; Ralf Janknecht
Journal:  Int J Clin Exp Med       Date:  2016-06-30

7.  A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein.

Authors:  Marius S Pop; Nicolas Stransky; Colin W Garvie; Jean-Philippe Theurillat; Emily C Hartman; Timothy A Lewis; Cheng Zhong; Elizabeth K Culyba; Fallon Lin; Douglas S Daniels; Raymond Pagliarini; Lucienne Ronco; Angela N Koehler; Levi A Garraway
Journal:  Mol Cancer Ther       Date:  2014-04-15       Impact factor: 6.261

8.  Glucose-Regulated Protein 94 Mediates the Proliferation and Metastasis through the Regulation of ETV1 and MAPK Pathway in Colorectal Cancer.

Authors:  Uyanga Batzorig; Po-Li Wei; Weu Wang; Chien-Yu Huang; Yu-Jia Chang
Journal:  Int J Med Sci       Date:  2021-03-27       Impact factor: 3.738

Review 9.  The mechanobiome: a goldmine for cancer therapeutics.

Authors:  Eleana Parajón; Alexandra Surcel; Douglas N Robinson
Journal:  Am J Physiol Cell Physiol       Date:  2020-11-11       Impact factor: 4.249

10.  Plakophilin-3 catenin associates with the ETV1/ER81 transcription factor to positively modulate gene activity.

Authors:  William A Munoz; Moonsup Lee; Rachel K Miller; Zamal Ahmed; Hong Ji; Todd M Link; Gilbert R Lee; Malgorzata Kloc; John E Ladbury; Pierre D McCrea
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.